Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jun 01, 2022 12:05pm

171 Views

Post# 34723557

RE:BTD

enriquesuave wrote: BTD can be applied for early on true, but if granted after fairly substantial data of 20-25 patients up to 450 days sort of guarantees that AA will follow if the trend continues. IMHO. So we wait a little more for BTD to shorten thereafter Accelerated FDA approval. Just IMHO. 4 more patients and we have 45. That means if 26-45 show a similar trend even if we don't wait til 450 days for all, then AA should be granted. I hope that is what is being set. All IMHO

Bravo!

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023